Brian Carr

921 total citations
36 papers, 707 citations indexed

About

Brian Carr is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Brian Carr has authored 36 papers receiving a total of 707 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Pharmacology and 10 papers in Molecular Biology. Recurrent topics in Brian Carr's work include Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Immunotherapy and Immune Responses (6 papers). Brian Carr is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Drug Transport and Resistance Mechanisms (8 papers) and Immunotherapy and Immune Responses (6 papers). Brian Carr collaborates with scholars based in United States, New Zealand and United Kingdom. Brian Carr's co-authors include Dan Hanson, Alan M. Krensky, Thomas J. Goralski, Xiaoyan Chu, Raymond Evers, Niresh Hariparsad, Garold S. Yost, Yulin Fang, Magang Shou and Ronald N. Hines and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Brian Carr

35 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Carr United States 15 214 204 180 125 99 36 707
Liliane Cicéron France 17 213 1.0× 149 0.7× 68 0.4× 76 0.6× 110 1.1× 28 934
Rachel Swiss United States 13 327 1.5× 49 0.2× 215 1.2× 113 0.9× 130 1.3× 17 845
Maria Luisa Dupuis Italy 20 525 2.5× 228 1.1× 56 0.3× 284 2.3× 12 0.1× 50 1.2k
Sawako Itagaki Japan 13 190 0.9× 453 2.2× 41 0.2× 56 0.4× 19 0.2× 22 1.0k
Johanna Raffetseder Sweden 14 308 1.4× 368 1.8× 83 0.5× 41 0.3× 19 0.2× 23 835
Houcemeddine Othman Tunisia 15 405 1.9× 72 0.4× 34 0.2× 45 0.4× 75 0.8× 48 766
Kamran Kadkhoda Canada 16 582 2.7× 179 0.9× 19 0.1× 146 1.2× 121 1.2× 33 1.2k
Misty Saracino United States 15 250 1.2× 65 0.3× 19 0.1× 147 1.2× 115 1.2× 23 729
Hamzeh Rahimi Iran 15 323 1.5× 69 0.3× 25 0.1× 74 0.6× 32 0.3× 69 653
Cristina D. Rodrigues Portugal 10 381 1.8× 155 0.8× 32 0.2× 82 0.7× 16 0.2× 11 913

Countries citing papers authored by Brian Carr

Since Specialization
Citations

This map shows the geographic impact of Brian Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Carr more than expected).

Fields of papers citing papers by Brian Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Carr. The network helps show where Brian Carr may publish in the future.

Co-authorship network of co-authors of Brian Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Carr. A scholar is included among the top collaborators of Brian Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Carr. Brian Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rappaport, Amy, Elena Bekerman, Brian Carr, et al.. (2025). Differential shaping of T cell responses elicited by heterologous ChAd68/self-amplifying mRNA SIV vaccine in macaques in combination with αCTLA4, αPD-1, or FLT3R agonist. The Journal of Immunology. 214(3). 489–501. 1 indexed citations
3.
Moldt, Brian, Abishek Chandrashekar, Erica N. Borducchi, et al.. (2022). HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys. PLoS Pathogens. 18(4). e1010467–e1010467. 23 indexed citations
4.
Barrett, Stephanie E., Marc Abrams, Rob S. Burke, et al.. (2014). An in vivo evaluation of amphiphilic, biodegradable peptide copolymers as siRNA delivery agents. International Journal of Pharmaceutics. 466(1-2). 58–67. 13 indexed citations
5.
Hammer, Philip E., Brian Carr, Rong Guo, et al.. (2008). Characterization and plant expression of a glyphosate‐tolerant enolpyruvylshikimate phosphate synthase. Pest Management Science. 64(4). 340–345. 11 indexed citations
6.
7.
Prueksaritanont, Thomayant, et al.. (2006). Rifampin Induces the in Vitro Oxidative Metabolism, but Not the in Vivo Clearance of Diclofenac in Rhesus Monkeys. Drug Metabolism and Disposition. 34(11). 1806–1810. 4 indexed citations
8.
Tang, Cuyue, Yulin Fang, Catherine Booth-Genthe, et al.. (2006). Diclofenac hydroxylation in monkeys: Efficiency, regioselectivity, and response to inhibitors. Biochemical Pharmacology. 73(6). 880–890. 14 indexed citations
9.
Carr, Brian, Yulin Fang, Ping Lu, et al.. (2006). Characterization of the Rhesus Monkey CYP3A64 Enzyme: Species Comparisons of CYP3A Substrate Specificity and Kinetics Using Baculovirus-Expressed Recombinant Enzymes. Drug Metabolism and Disposition. 34(10). 1703–1712. 48 indexed citations
10.
Prueksaritanont, Thomayant, Yuhsin Kuo, Cuyue Tang, et al.. (2006). In Vitro and in Vivo CYP3A64 Induction and Inhibition Studies in Rhesus Monkeys: A Preclinical Approach for CYP3A-Mediated Drug Interaction Studies. Drug Metabolism and Disposition. 34(9). 1546–1555. 22 indexed citations
11.
Lü, Ping, Suresh B. Singh, Brian Carr, et al.. (2005). Selective Inhibition of Dog Hepatic CYP2B11 and CYP3A12. Journal of Pharmacology and Experimental Therapeutics. 313(2). 518–528. 29 indexed citations
12.
Wan, Jie, Brian Carr, N. Shane Cutler, et al.. (2005). SP1 AND SP3 REGULATE BASAL TRANSCRIPTION OF THE HUMAN CYP2F1 GENE. Drug Metabolism and Disposition. 33(8). 1244–1253. 15 indexed citations
13.
Carr, Brian, et al.. (2003). Characterization of Pulmonary CYP4B2, Specific Catalyst of Methyl Oxidation of 3-Methylindole. Molecular Pharmacology. 63(5). 1137–1147. 15 indexed citations
14.
Carr, Brian, Jie Wan, Ronald N. Hines, & Garold S. Yost. (2003). Characterization of the Human Lung CYP2F1 Gene and Identification of a Novel Lung-specific Binding Motif. Journal of Biological Chemistry. 278(18). 15473–15483. 31 indexed citations
15.
Carr, Brian, et al.. (1998). Drug-metabolizing enzyme induction by 2,2′-dipyridyl, 1,7-phenanthroline, 7,8-benzoquinoline and oltipraz in mouse. Xenobiotica. 28(10). 949–956. 16 indexed citations
16.
Kulkosky, Paul J., et al.. (1996). Angiotensin II reduces alcohol intake and choice in water- or food-restricted rats. Alcohol. 13(4). 359–363. 6 indexed citations
17.
Carr, Brian, et al.. (1995). Glucagon produces delayed increase in drinking-associated food intake. UTC Scholar (University of Tennessee at Chattanooga). 3(2). 5. 1 indexed citations
18.
Kulkosky, Paul J., et al.. (1995). Conditioned Taste Aversions Induced by Alcohol and Lithium in Rats Selectively Bred for Ethanol Neurosensitivity. Alcoholism Clinical and Experimental Research. 19(4). 945–950. 7 indexed citations
19.
Carr, Brian, et al.. (1994). Desmethionine-bombesin receptor antagonist blocks bombesin-induced inhibition of alcohol intake. Alcohol. 11(2). 125–131. 1 indexed citations
20.
Carr, Brian, et al.. (1993). MK-329 blocks the inhibition of alcohol intake by CCK-8. Peptides. 14(6). 1193–1197. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liliane Cicéron Breakdown of academic impact, for papers by Rachel Swiss Breakdown of academic impact, for papers by Maria Luisa Dupuis Breakdown of academic impact, for papers by Sawako Itagaki Breakdown of academic impact, for papers by Johanna Raffetseder Breakdown of academic impact, for papers by Houcemeddine Othman Breakdown of academic impact, for papers by Kamran Kadkhoda Breakdown of academic impact, for papers by Misty Saracino Breakdown of academic impact, for papers by Hamzeh Rahimi Breakdown of academic impact, for papers by Cristina D. Rodrigues
Rankless by CCL
2026